Beta Bionics, Inc. (NASDAQ: BBNX) reported Q3 EPS of ($0.52), $0.20 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $35.5 million.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.